The Indian SARS-CoV-2 Genomics Consortium (INSACOG) seeks to use multi-laboratory network to monitor the genomic variations in the SARS-CoV-2 on the regular basis in order to help develop potential vaccines in the future. It comes under the aegis of the National Centre for Disease Control (NCDC). It was formed in response to the new COVID-19 strain detected in the United Kingdom. More than 50 samples of UK returnees are currently under sequencing at the designated laboratories.
No comments yet.